IMMUNOVEDA Trademark

Trademark Overview

On Wednesday, October 23, 2019, a trademark application was filed for IMMUNOVEDA with the United States Patent and Trademark Office. The USPTO has given the IMMUNOVEDA trademark a serial number of 88664944. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 23, 2023. This trademark is owned by Genesis Drug, Discovery & Development, LLC. The IMMUNOVEDA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical treatment of cancer; Medical diagnosis and treatment of cancer; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer
immunoveda

General Information

Serial Number88664944
Word MarkIMMUNOVEDA
Filing DateWednesday, October 23, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2020

Trademark Statements

Goods and ServicesMedical treatment of cancer; Medical diagnosis and treatment of cancer; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 29, 2019
Primary Code044
First Use Anywhere DateSaturday, October 31, 2020
First Use In Commerce DateSaturday, October 31, 2020

Trademark Owner History

Party NameGenesis Drug, Discovery & Development, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690
Party NameGenesis Drug, Discovery & Development, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Trademark Events

Event DateEvent Description
Wednesday, August 23, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, August 23, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, August 23, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, May 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 9, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 9, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, April 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 4, 2023USE AMENDMENT FILED
Tuesday, April 4, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, September 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 20, 2022SOU EXTENSION 5 GRANTED
Wednesday, September 14, 2022SOU EXTENSION 5 FILED
Wednesday, September 14, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 12, 2022SOU EXTENSION 4 GRANTED
Tuesday, April 5, 2022SOU EXTENSION 4 FILED
Tuesday, April 5, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, September 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 24, 2021SOU EXTENSION 3 GRANTED
Friday, September 24, 2021SOU EXTENSION 3 FILED
Friday, September 24, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 19, 2021SOU EXTENSION 2 GRANTED
Thursday, April 1, 2021SOU EXTENSION 2 FILED
Thursday, April 1, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, April 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 14, 2020SOU EXTENSION 1 GRANTED
Thursday, April 9, 2020SOU EXTENSION 1 FILED
Tuesday, April 14, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 9, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 8, 2020ASSIGNED TO EXAMINER
Tuesday, October 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 26, 2019NEW APPLICATION ENTERED

Related Keywords

immunoveda treatment medical cancer purposes diagnostic testing field diagnosis